Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLetter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.AuthorsChen, Y. C.; Liaw, Y. F.AbstractA letter to the editor is presented in response to the article "Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance," by P. P. Gounder and colleagues in the 2016 issue.SubjectsCANCER risk factors; LIVER cancer; HEPATITIS associated antigen; HEPATITIS BPublicationAlimentary Pharmacology & Therapeutics, 2016, Vol 44, Issue 2, p210ISSN0269-2813Publication typeArticleDOI10.1111/apt.13674